Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 856 shares at $152.05 ($130K) on 2021-03-02, disclosed to the SEC on 2021-03-04.
Open-market sale of $130k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.05 | 428 | $65K | 50.0% |
| 2 | $152.05 | 428 | $65K | 50.0% |
| Total | $152.05 avg | 856 | $130K | 100% |
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |